A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

NCT07363707 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

NAFLD (Nonalcoholic Fatty Liver Disease)

Interventions

DRUG: Dapagliflozin + Metformin
DRUG: Empa

Sponsor

Beni-Suef University